Evidence map›Paper›PMID 36597019›Full record

ArticleBMC bioinformatics2023

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology.

Yauheniya Zhdanovich, Jörg Ackermann, Peter J Wild, Jens Köllermann, Katrin Bankov, Claudia Döring, Nadine Flinner, Henning Reis, Mike Wenzel, Benedikt Höh and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 28 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Yauheniya ZhdanovichInstitute of Pathology, Ludwig-Maximilians University Munich, Thalkirchner Str. 36, 80337, Munich, Germany.
Jörg AckermannMolecular Bioinformatics Group, Institute of Computer Science, Faculty of Computer Science and Mathematics, Robert-Mayer-Straße 11-15, 60325, Frankfurt, Germany.
Peter J WildDr. Senckenberg Institute for Pathology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Jens KöllermannDr. Senckenberg Institute for Pathology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Katrin BankovDr. Senckenberg Institute for Pathology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Claudia DöringDr. Senckenberg Institute for Pathology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Nadine FlinnerDr. Senckenberg Institute for Pathology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Henning ReisDr. Senckenberg Institute for Pathology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Mike WenzelDepartment of Urology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Benedikt HöhDepartment of Urology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Philipp MandelDepartment of Urology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Thomas J VoglDepartment of Diagnostic and Interventional Radiology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany.
Patrick HarterNeurological Institute (Edinger Institute), University Hospital Frankfurt, 60590, Frankfurt, Germany.
Katharina FilipskiNeurological Institute (Edinger Institute), University Hospital Frankfurt, 60590, Frankfurt, Germany.
Ina KochMolecular Bioinformatics Group, Institute of Computer Science, Faculty of Computer Science and Mathematics, Robert-Mayer-Straße 11-15, 60325, Frankfurt, Germany.
Simon BernatzDr. Senckenberg Institute for Pathology, Goethe University Frankfurt am Main, University Hospital Frankfurt, 60590, Frankfurt, Germany. Simon.Bernatz@kgu.de.
Goethe University Frankfurt · DEUniversity Hospital Frankfurt · DEFrankfurt Institute for Advanced Studies · DEHumboldt-Universität zu Berlin · DE

Funding

Hessen State Ministry for Higher Education, Research and the Arts III L 5 - 519/03/03.001 - (0015)
6 · The paper itself

Abstract

backgroundProstate cancer is a major health concern in aging men. Paralleling an aging society, prostate cancer prevalence increases emphasizing the need for efficient diagnostic algorithms.

methodsRetrospectively, 106 prostate tissue samples from 48 patients (mean age, [Formula: see text] years) were included in the study. Patients suffered from prostate cancer (n = 38) or benign prostatic hyperplasia (n = 10) and were treated with radical prostatectomy or Holmium laser enucleation of the prostate, respectively. We constructed tissue microarrays (TMAs) comprising representative malignant (n = 38) and benign (n = 68) tissue cores. TMAs were processed to histological slides, stained, digitized and assessed for the applicability of machine learning strategies and open-source tools in diagnosis of prostate cancer. We applied the software QuPath to extract features for shape, stain intensity, and texture of TMA cores for three stainings, H&E, ERG, and PIN-4. Three machine learning algorithms, neural network (NN), support vector machines (SVM), and random forest (RF), were trained and cross-validated with 100 Monte Carlo random splits into 70% training set and 30% test set. We determined AUC values for single color channels, with and without optimization of hyperparameters by exhaustive grid search. We applied recursive feature elimination to feature sets of multiple color transforms.

resultsMean AUC was above 0.80. PIN-4 stainings yielded higher AUC than H&E and ERG. For PIN-4 with the color transform saturation, NN, RF, and SVM revealed AUC of [Formula: see text], [Formula: see text], and [Formula: see text], respectively. Optimization of hyperparameters improved the AUC only slightly by 0.01. For H&E, feature selection resulted in no increase of AUC but to an increase of 0.02-0.06 for ERG and PIN-4.

conclusionsAutomated pipelines may be able to discriminate with high accuracy between malignant and benign tissue. We found PIN-4 staining best suited for classification. Further bioinformatic analysis of larger data sets would be crucial to evaluate the reliability of automated classification methods for clinical practice and to evaluate potential discrimination of aggressiveness of cancer to pave the way to automatic precision medicine.

Indexed as

ProstateProstatic NeoplasmsAlgorithmsHumansMaleReproducibility of ResultsRetrospective StudiesMachine learningPredictionProstate cancerQuantitative featuresStatistical analysis

Identifiers

PMID36597019
PMCPMC9809030
OpenAlexW4313523866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.